
Merck and Moderna Achieve First Phase 3 Cancer Vaccine Breakthrough
TOP NEWS HEADLINES Merck and Moderna just announced the first positive Phase 3 results for an AI-designed personalized cancer vaccine - the therapy cuts melanoma recurrence in half and reduces spr...
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.